Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by SizzlinSteakson May 22, 2018 11:18am

124 Views

Post# 28063384

RE:RE:RE:RE:RE:S.204 plus 312.81 title 21

Phase 1b is not complete yet. Patients 7, 8 and 9 still remain to be treated. However, having 6 patients completed with 100% success at 90 days, FDA and HC approval is pretty much a given.

It is estimated that 1 patient per month is enrolled. Therefore phase 1b should be complete sometime this fall.